Tigecycline for Injection USP 50mg | EMTIG - Emcure

Advanced Broad-Spectrum Intravenous Antibiotic

When managing complicated, severe, or multidrug-resistant bacterial infections, healthcare providers require a highly potent and reliable intervention. The Tigecycline for Injection USP 50 mg (commercially recognized as EMTIG) provides an aggressive, broad-spectrum glycylcycline antibiotic therapy designed specifically for intravenous (I.V.) infusion. Manufactured by Emcure, a globally respected leader in critical care pharmaceuticals, this single-dose lyophilized vial ensures the steady clinical performance necessary for acute care and intensive recovery protocols.

Why Choose EMTIG for Critical Infection Management?

Tackling resistant bacterial strains—including complex intra-abdominal infections and complicated skin and skin structure infections—requires a sophisticated approach. Instead of relying on standard antibiotics that bacteria may easily bypass, clinical specialists benefit from EMTIG’s robust mechanism of action, which effectively inhibits bacterial protein synthesis. This provides hospitals and specialized clinics with a highly reliable defense against challenging Gram-positive and Gram-negative pathogens. Emcure ensures the absolute, stringent quality control demanded in intensive care environments.

Key Product Specifications & Clinical Benefits

Potent Active Ingredient: Each vial contains premium-grade Tigecycline USP equivalent to 50 mg, delivering a highly concentrated and powerful antibiotic dose.

Lyophilized Stability: Supplied as a lyophilized (freeze-dried) powder, ensuring maximum stability and potency of the active ingredient until the exact moment of clinical reconstitution.

Targeted Intravenous Delivery: Formulated strictly for I.V. Infusion Only, guaranteeing optimal systemic bioavailability for a rapid therapeutic response in acute hospital settings.

Hygienic Single-Dose Vial: Packaged as a sterile, single-dose glass vial, minimizing the risk of cross-contamination during critical care preparation.

Essential Storage & Usage Guidelines

Maintaining the integrity of this critical care medication is vital for its clinical efficacy. Store the un-reconstituted vial at a temperature below 25°C. Reconstitute precisely with 5 ml of 0.9% w/v Sodium Chloride Injection IP or 5% Dextrose Injection IP as directed. After reconstitution, do not use if any foreign particulate matter is observed. Do not use if the vial seal is broken.

Important Notice: EMTIG is a Schedule H Prescription Drug. Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner. It must be prepared and administered strictly in a clinical or hospital setting. Keep all medicines safely out of the reach of children.